Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia
- PMID: 21244564
- DOI: 10.1111/j.1600-0897.2011.00981.x
Serum anti-carbonic anhydrase II antibodies and oxidant-antioxidant balance in pre-eclampsia
Abstract
PROBLEM The aim of this study was to investigate the presence of anti-carbonic anhydrase II antibodies (anti-CA II) antibodies in pre-eclampsia and the relationships between the autoantibodies, total antioxidant capacity (TAC) and total oxidant capacity (TOC), malondialdehyde (MDA) and oxidative stres index (OSI) parameters. METHOD OF STUDY We studied 40 early and late onset pre-eclamptic patients and 40 healthy pregnant control and 39 healthy non-pregnant control subjects. Serum CA II antibodies, TAC and TOC, and MDA parameters were studied by ELISA. RESULTS The mean values for TAC, TOC, OSI, MDA, and anti-CA II were significantly increased in patients with pre-eclampsia compared to the other groups. The anti-CA II antibody levels for the pregnant control subjects were 0.129 ± 0.04 and that for the pre-eclamptic patients were 0.282 ± 0.18. In this study, any absorbance value higher than 0.136, the mean absorbance + 2 S.D. of pregnant control subjects, was defined as positive. Positive results were obtained in 29 of 40 pre-eclamptic patients (72.5%). There were significant positive correlations between serum anti-CA II antibodies and TOC, MDA levels, and OSI levels. CONCLUSION The results suggest that anti-CA II antibodies and impairment in oxidant-antioxidant balance may be involved in multifactorial etiology of pre-eclampsia.
© 2011 John Wiley & Sons A/S.
Similar articles
-
Serum anti-carbonic anhydrase antibodies and oxidant-antioxidant balance in patients with acute anterior uveitis.Ocul Immunol Inflamm. 2014 Apr;22(2):127-32. doi: 10.3109/09273948.2013.830753. Epub 2013 Sep 24. Ocul Immunol Inflamm. 2014. PMID: 24063704
-
Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease.Exp Clin Endocrinol Diabetes. 2007 May;115(5):287-91. doi: 10.1055/s-2007-960498. Exp Clin Endocrinol Diabetes. 2007. PMID: 17516290
-
Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis.Clin Biochem. 2011 Dec;44(17-18):1385-9. doi: 10.1016/j.clinbiochem.2011.09.014. Epub 2011 Oct 2. Clin Biochem. 2011. PMID: 21986594
-
Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk.Arch Gynecol Obstet. 2011 Dec;284(6):1367-73. doi: 10.1007/s00404-011-1865-2. Epub 2011 Feb 23. Arch Gynecol Obstet. 2011. PMID: 21344259
-
The potential therapeutic effects of ergothioneine in pre-eclampsia.Free Radic Biol Med. 2018 Mar;117:145-157. doi: 10.1016/j.freeradbiomed.2017.12.030. Epub 2017 Dec 25. Free Radic Biol Med. 2018. PMID: 29284116 Review.
Cited by
-
Oxidative damage, inflammation, and Toll-like receptor 4 pathway are increased in preeclamptic patients: a case-control study.Oxid Med Cell Longev. 2012;2012:636419. doi: 10.1155/2012/636419. Epub 2012 Jun 24. Oxid Med Cell Longev. 2012. PMID: 22792416 Free PMC article.
-
Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia.Turk J Haematol. 2017 Dec 1;34(4):307-313. doi: 10.4274/tjh.2016.0341. Epub 2017 Mar 8. Turk J Haematol. 2017. PMID: 28270370 Free PMC article.
-
Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.J Med Toxicol. 2015 Jun;11(2):265-73. doi: 10.1007/s13181-015-0472-1. J Med Toxicol. 2015. PMID: 25876064 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials